サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：心筋炎の世界市場規模：タイプ別、治療別、診断別、流通チャネル別、地域別予測（2022年～2028年）
市場調査レポート
商品コード
1084071

心筋炎の世界市場規模：タイプ別、治療別、診断別、流通チャネル別、地域別予測（2022年～2028年）

Global Myocarditis Disease Market Size study, By Type, By Treatment, By Diagnosis, By Distribution Channel, and Regional Forecasts 2022-2028
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
心筋炎の世界市場規模：タイプ別、治療別、診断別、流通チャネル別、地域別予測（2022年～2028年）
出版日: 2022年05月27日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の心筋炎の市場規模は、慢性疾患の有病率の上昇、医療費の増加、先進技術の開発の増加、医薬品の承認・上市数の増加、可用性の向上、研究開発活動の増加などによって促進されています。

一方で、熟練した専門家の不足や人々の認識不足が、予測期間における同市場の成長を抑制する可能性があります。

当レポートでは、世界の心筋炎市場を調査しており、市場の概要、市場分析、タイプ・治療・診断・流通チャネル・地域別の分析、および競合情勢など、包括的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界の心筋炎市場の定義と範囲

第3章 世界の心筋炎市場力学

  • 心筋炎市場の影響分析（2020年～2028年）

第4章 世界の心筋炎市場の業界分析

  • ポーターのファイブフォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論
  • 主要投資機会
  • 主要成功戦略

第5章 リスク評価：COVID-19の影響

    • 業界に対するCOVID-19の全体的な影響の評価
    • COVID-19以前およびCOVID-19後の市場シナリオ

第6章 世界の心筋炎市場：タイプ別

  • 市場スナップショット
  • タイプ別の世界の心筋炎市場の実績-潜在性分析
  • タイプ別の世界の心筋炎市場の推定と予測（2018年～2028年）
  • 心筋炎市場、サブセグメント分析
    • 急性心筋炎
    • 慢性心筋炎
    • リンパ球性心筋炎

第7章 世界の心筋炎市場：治療別

  • 市場スナップショット
  • 治療別の世界の心筋炎市場の実績-潜在性分析
  • 治療別の世界の心筋炎市場の推定と予測（2018年～2028年）
  • 心筋炎市場、サブセグメント分析
    • 投薬
    • 手術
    • その他

第8章 世界の心筋炎市場：診断別

  • 市場スナップショット
  • 診断別の世界の心筋炎市場の実績-潜在性分析
  • 診断別の世界の心筋炎市場の推定と予測（2018年～2028年）
  • 心筋炎市場、サブセグメント分析
    • 血液検査
    • 画像検査
    • 心臓カテーテル
    • 心臓筋生検
    • その他

第9章 世界の心筋炎市場：流通チャネル別

  • 市場スナップショット
  • 流通チャネル別の世界の心筋炎市場の実績-潜在性分析
  • 流通チャネル別の世界の心筋炎市場の推定と予測（2018年～2028年）
  • 心筋炎市場、サブセグメント分析
    • 病院薬局
    • 小売薬局
    • オンライン薬局
    • その他

第10章 世界の心筋炎市場：地域別

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカスナップショット
    • ブラジル
    • メキシコ
  • その他の地域

第11章 競合情報

  • 主要市場戦略
  • 企業プロファイル
    • F. Hoffmann-La Roche Ltd.
    • Mylan N.V.
    • Teva Pharmaceutical Industries Ltd.
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Novartis AG
    • Johnson & Johnson
    • Bayer AG
    • Sun Pharmaceutical Industries Ltd.
    • Merck & Co., Inc.

第12章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Myocarditis Disease Market, report scope
  • TABLE 2. Global Myocarditis Disease Market estimates & forecasts by Region 2018-2028 (USD Million)
  • TABLE 3. Global Myocarditis Disease Market estimates & forecasts by Type 2018-2028 (USD Million)
  • TABLE 4. Global Myocarditis Disease Market estimates & forecasts by Treatment 2018-2028 (USD Million)
  • TABLE 5. Global Myocarditis Disease Market estimates & forecasts by Diagnosis 2018-2028 (USD Million)
  • TABLE 6. Global Myocarditis Disease Market estimates & forecasts by Distribution Channel 2018-2028 (USD Million)
  • TABLE 7. Global Myocarditis Disease Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 8. Global Myocarditis Disease Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 9. Global Myocarditis Disease Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 10. Global Myocarditis Disease Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 11. Global Myocarditis Disease Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 12. Global Myocarditis Disease Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 13. Global Myocarditis Disease Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 14. Global Myocarditis Disease Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 15. Global Myocarditis Disease Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 16. Global Myocarditis Disease Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 17. U.S. Myocarditis Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 18. U.S. Myocarditis Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 19. U.S. Myocarditis Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 20. Canada Myocarditis Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 21. Canada Myocarditis Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 22. Canada Myocarditis Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 23. UK Myocarditis Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 24. UK Myocarditis Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 25. UK Myocarditis Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 26. Germany Myocarditis Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 27. Germany Myocarditis Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 28. Germany Myocarditis Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 29. RoE Myocarditis Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 30. RoE Myocarditis Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 31. RoE Myocarditis Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 32. China Myocarditis Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 33. China Myocarditis Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 34. China Myocarditis Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 35. India Myocarditis Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 36. India Myocarditis Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 37. India Myocarditis Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 38. Japan Myocarditis Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 39. Japan Myocarditis Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 40. Japan Myocarditis Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 41. RoAPAC Myocarditis Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 42. RoAPAC Myocarditis Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 43. RoAPAC Myocarditis Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 44. Brazil Myocarditis Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 45. Brazil Myocarditis Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 46. Brazil Myocarditis Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 47. Mexico Myocarditis Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 48. Mexico Myocarditis Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 49. Mexico Myocarditis Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 50. RoLA Myocarditis Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 51. RoLA Myocarditis Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 52. RoLA Myocarditis Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 53. Row Myocarditis Disease Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 54. Row Myocarditis Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 55. Row Myocarditis Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 56. List of secondary sources, used in the study of global Myocarditis Disease Market
  • TABLE 57. List of primary sources, used in the study of global Myocarditis Disease Market
  • TABLE 58. Years considered for the study
  • TABLE 59. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Myocarditis Disease Market, research methodology
  • FIG 2. Global Myocarditis Disease Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Myocarditis Disease Market, key trends 2021
  • FIG 5. Global Myocarditis Disease Market, growth prospects 2022-2028
  • FIG 6. Global Myocarditis Disease Market, porters 5 force model
  • FIG 7. Global Myocarditis Disease Market, pest analysis
  • FIG 8. Global Myocarditis Disease Market, value chain analysis
  • FIG 9. Global Myocarditis Disease Market by segment, 2018 & 2028 (USD Million)
  • FIG 10. Global Myocarditis Disease Market by segment, 2018 & 2028 (USD Million)
  • FIG 11. Global Myocarditis Disease Market by segment, 2018 & 2028 (USD Million)
  • FIG 12. Global Myocarditis Disease Market by segment, 2018 & 2028 (USD Million)
  • FIG 13. Global Myocarditis Disease Market by segment, 2018 & 2028 (USD Million)
  • FIG 14. Global Myocarditis Disease Market, regional snapshot 2018 & 2028
  • FIG 15. North America Myocarditis Disease Market 2018 & 2028 (USD Million)
  • FIG 16. Europe Myocarditis Disease Market 2018 & 2028 (USD Million)
  • FIG 17. Asia Pacific Myocarditis Disease market 2018 & 2028 (USD Million)
  • FIG 18. Latin America Myocarditis Disease Market 2018 & 2028 (USD Million)
  • FIG 19. Global Myocarditis Disease Market, company market share analysis (2021)
目次

Global Myocarditis Disease Market is valued at approximately USDXX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Myocarditis is a condition that is caused by a viral infection in which the heart muscle (myocardium) becomes inflamed. In this state, an individual's heart is unable to pump blood adequately to other regions of the body. The rising prevalence of chronic disorders, growing healthcare expenditure, and increasing development of advanced technologies are several factors propelling the market demand across the globe. For instance, according to the Centers for Medicare and Medicaid Services, national healthcare expenditure in the United States was recorded at USD 4.1 trillion in 2020, or USD 12,530 per person, and accounted for 19.7% of GDP (GDP). Furthermore, national health spending is expected to rise at a 5.4 percent annual rate from 2019 to 2028, likely to reach USD 6.2 trillion. Consequentially, the rising healthcare spending by the population is demonstrating a positive influence on the market demand, which, in turn, augments the market growth worldwide. However, the dearth of skilled professionals and lack of awareness among people impede the growth of the market over the forecast period of 2022-2028. Also, the rising number of drug approvals and launches and the growing availability and increasing research and development activities are anticipated to act as catalyzing factors for the market demand during the forecast period.

The key regions considered for the global Myocarditis Disease Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the availability of improved healthcare facilities and the presence of several leading market players. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the growing geriatric population, as well as the rising investment in R&D activities, would create lucrative growth prospects for the Myocarditis Disease Market across the Asia-Pacific region.

Major market players included in this report are:

F. Hoffmann-La Roche Ltd.

Mylan N.V.

Teva Pharmaceutical Industries Ltd.

Pfizer Inc.

GlaxoSmithKline plc

Novartis AG

Johnson & Johnson

Bayer AG

Sun Pharmaceutical Industries Ltd.

Merck & Co., Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Acute Myocarditis

Chronic Myocarditis

Lymphocytic Myocarditis

By Treatment:

Medication

Surgery

Others

By Diagnosis:

Blood Tests

Imaging Tests

Cardiac Catheterization

Heart Muscle Biopsy

Others

By Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Myocarditis Disease Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
    • 1.2.1. Myocarditis Disease Market, by Region, 2020-2028 (USD Million)
    • 1.2.2. Myocarditis Disease Market, by Type, 2020-2028 (USD Million)
    • 1.2.3. Myocarditis Disease Market, by Treatment, 2020-2028 (USD Million)
    • 1.2.4. Myocarditis Disease Market, by Diagnosis, 2020-2028 (USD Million)
    • 1.2.5. Myocarditis Disease Market, by Distribution Channel, 2020-2028 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Myocarditis Disease Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Myocarditis Disease Market Dynamics

  • 3.1. Myocarditis Disease Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising prevalence of chronic disorders
      • 3.1.1.2. Growing healthcare expenditure
    • 3.1.2. Market Challenges
      • 3.1.2.1. Dearth of skilled professionals
      • 3.1.2.2. Lack of awareness among people
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising number of drug approvals and launches
      • 3.1.3.2. Growing availability and increasing research and development activities

Chapter 4. Global Myocarditis Disease Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Myocarditis Disease Market, by Type

  • 6.1. Market Snapshot
  • 6.2. Global Myocarditis Disease Market by Type, Performance - Potential Analysis
  • 6.3. Global Myocarditis Disease Market Estimates & Forecasts by Type, 2018-2028 (USD Million)
  • 6.4. Myocarditis Disease Market, Sub Segment Analysis
    • 6.4.1. Acute Myocarditis
    • 6.4.2. Chronic Myocarditis
    • 6.4.3. Lymphocytic Myocarditis

Chapter 7. Global Myocarditis Disease Market, by Treatment

  • 7.1. Market Snapshot
  • 7.2. Global Myocarditis Disease Market by Treatment, Performance - Potential Analysis
  • 7.3. Global Myocarditis Disease Market Estimates & Forecasts by Treatment, 2018-2028 (USD Million)
  • 7.4. Myocarditis Disease Market, Sub Segment Analysis
    • 7.4.1. Medication
    • 7.4.2. Surgery
    • 7.4.3. Others

Chapter 8. Global Myocarditis Disease Market, by Diagnosis

  • 8.1. Market Snapshot
  • 8.2. Global Myocarditis Disease Market by Diagnosis, Performance - Potential Analysis
  • 8.3. Global Myocarditis Disease Market Estimates & Forecasts by Diagnosis, 2018-2028 (USD Million)
  • 8.4. Myocarditis Disease Market, Sub Segment Analysis
    • 8.4.1. Blood Tests
    • 8.4.2. Imaging Tests
    • 8.4.3. Cardiac Catheterization
    • 8.4.4. Heart Muscle Biopsy
    • 8.4.5. Others

Chapter 9. Global Myocarditis Disease Market, by Distribution Channel

  • 9.1. Market Snapshot
  • 9.2. Global Myocarditis Disease Market by Distribution Channel, Performance - Potential Analysis
  • 9.3. Global Myocarditis Disease Market Estimates & Forecasts by Distribution Channel, 2018-2028 (USD Million)
  • 9.4. Myocarditis Disease Market, Sub Segment Analysis
    • 9.4.1. Hospital Pharmacy
    • 9.4.2. Retail Pharmacy
    • 9.4.3. Online Pharmacy
    • 9.4.4. Others

Chapter 10. Global Myocarditis Disease Market, Regional Analysis

  • 10.1. Myocarditis Disease Market, Regional Market Snapshot
  • 10.2. North America Myocarditis Disease Market
    • 10.2.1. U.S. Myocarditis Disease Market
      • 10.2.1.1. Type breakdown estimates & forecasts, 2018-2028
      • 10.2.1.2. Treatment breakdown estimates & forecasts, 2018-2028
      • 10.2.1.3. Diagnosis breakdown estimates & forecasts, 2018-2028
      • 10.2.1.4. Distribution Channel breakdown estimates & forecasts, 2018-2028
    • 10.2.2. Canada Myocarditis Disease Market
  • 10.3. Europe Myocarditis Disease Market Snapshot
    • 10.3.1. U.K. Myocarditis Disease Market
    • 10.3.2. Germany Myocarditis Disease Market
    • 10.3.3. France Myocarditis Disease Market
    • 10.3.4. Spain Myocarditis Disease Market
    • 10.3.5. Italy Myocarditis Disease Market
    • 10.3.6. Rest of Europe Myocarditis Disease Market
  • 10.4. Asia-Pacific Myocarditis Disease Market Snapshot
    • 10.4.1. China Myocarditis Disease Market
    • 10.4.2. India Myocarditis Disease Market
    • 10.4.3. Japan Myocarditis Disease Market
    • 10.4.4. Australia Myocarditis Disease Market
    • 10.4.5. South Korea Myocarditis Disease Market
    • 10.4.6. Rest of Asia Pacific Myocarditis Disease Market
  • 10.5. Latin America Myocarditis Disease Market Snapshot
    • 10.5.1. Brazil Myocarditis Disease Market
    • 10.5.2. Mexico Myocarditis Disease Market
  • 10.6. Rest of The World Myocarditis Disease Market

Chapter 11. Competitive Intelligence

  • 11.1. Top Market Strategies
  • 11.2. Company Profiles
    • 11.2.1. F. Hoffmann-La Roche Ltd.
      • 11.2.1.1. Key Information
      • 11.2.1.2. Overview
      • 11.2.1.3. Financial (Subject to Data Availability)
      • 11.2.1.4. Product Summary
      • 11.2.1.5. Recent Developments
    • 11.2.2. Mylan N.V.
    • 11.2.3. Teva Pharmaceutical Industries Ltd.
    • 11.2.4. Pfizer Inc.
    • 11.2.5. GlaxoSmithKline plc
    • 11.2.6. Novartis AG
    • 11.2.7. Johnson & Johnson
    • 11.2.8. Bayer AG
    • 11.2.9. Sun Pharmaceutical Industries Ltd.
    • 11.2.10. Merck & Co., Inc.

Chapter 12. Research Process

  • 12.1. Research Process
    • 12.1.1. Data Mining
    • 12.1.2. Analysis
    • 12.1.3. Market Estimation
    • 12.1.4. Validation
    • 12.1.5. Publishing
  • 12.2. Research Attributes
  • 12.3. Research Assumption